Methamphetamine and Other Substance Use During Pregnancy: Preliminary Estimates From the Infant Development, Environment, and Lifestyle (IDEAL) Study

详细信息    查看全文

• 作者：Amelia M. Arria PhD (1) (11)
  Chris Derauf MD (2)
  Linda L. LaGasse PhD (3)
  Penny Grant MD (4)
  Rizwan Shah MD (5)
  Lynne Smith MD (6)
  William Haning MD (7)
  Marilyn Huestis PhD (8)
  Arthur Strauss MD (9)
  Sheri Della Grotta MPH (3)
  Jing Liu PhD (3)
  Barry Lester PhD (10)
  
• 关键词：methamphetamine ; pregnancy ; alcohol and other drug use ; prenatal care ; epidemiology
• 刊名：Maternal and Child Health Journal
• 出版年：2006
• 出版时间：May 2006
• 年：2006
• 卷：10
• 期：3
• 页码：293-302
• 全文大小：245KB
• 参考文献：1. Lester BM, Andreozzi L, Appiah L. Substance use during pregnancy: Time for policy to catch up with research. / Harm Reduction J 2004;1(5):1鈥?4. CrossRef
  2. Hanson JW, Jones KL, Smith DW. Fetal alcohol syndrome. Experience with 41 patients. / JAMA 1976;235(14):1458鈥?0. CrossRef
  3. Bauer CR. Perinatal effects of prenatal drug exposure: Neonatal aspects. / Clin Perinatol 1999;26:87鈥?06.
  4. Streissguth AP, Barr HM, Martin DC, Herman CS. Effects of maternal alcohol nicotine, and caffeine use during pregnancy on infant mental and motor development at eight months. / Alc Clin Exp Res 1980;4(2):152鈥?4. CrossRef
  5. Kramer MS. The etiology and prevention of low birthweight: Current knowledge and priorities for future research. In: Berendes H, Kessel S Yaffe S, (Eds.) / Advances in the prevention of low birthweight. An international symposium. Washington, DC: National Center for Education in Maternal and Child Health, 1991.
  6. Lassen K, Oei TPS. Effects of maternal cigarette smoking during pregnancy on long-term physical and cognitive parameters of child development. / Addict Behav 23:635鈥?3.
  7. Law KL, Stroud LR, LaGasse LL, Niaura R. Smoking during pregnancy and newborn neurobehavior. / Pediatrics 2003;111(6):1318鈥?3. CrossRef
  8. Kandall SR, Albin S, Gartner LM, Lee KS, Eldelman A, Lowinson J. The narcotic-dependent mother: Fetal and neonatal consequences. / Early Hum Dev 1977;1(2):159鈥?9. CrossRef
  9. Finnegan LP, Kaltenbach KA. Neonatal abstinence syndrome. In: Hoekelman RA, Nelson NM, Seidel HM, (Eds.) / Primary Pediatric Care, 2nd Ed. St. Louis: Mosby, 1992: 1367鈥?8.
  10. Rangel C. The crack cocaine crisis (Joint hearings of Select Committee on Narcotics Abuse and control and select committee on children youth and families). Washington, DC, U.S. House of Representatives, 1986.
  11. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: The meaning of subtle effects. / Science 1998;282:633鈥?. CrossRef
  12. Delaney-Black V, Covington C, Templin T, Ager J. Prenatal cocaine exposure and child behavior. / Pediatrics 1998;102:945鈥?0. CrossRef
  13. Leech S, Richardson GA, Goldschmidt L, Day NL. Prenatal substance exposure: Effects on attention and impulsivity of 6-year olds. / Neurotoxicol Teratol 1999;21(2):109鈥?8. CrossRef
  14. Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure effects on the development of school-age children. / Neurotoxicol Terat 1996;18(6):627鈥?4. CrossRef
  15. Messinger DS, Bauer CR, Abhik D, Seifer R, Lester BM, Lagasse LL, Wright LL, Shankaran S, Bada HS, Smergilio VL, Langer JC, Beeghly M, Poole WK. The maternal lifestyle study: cognitive motor and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. / Pediatrics 113:1677鈥?5.
  16. Lester BM. Vulnerable Infants Program of Rhode Island. Program funded by the Robert Wood Johnson Local Initiative Funding Partners Program and the Abandoned Infant Assistance Project, 2000.
  17. Smeriglio VL, Wilcox HC. Prenatal drug exposure and child outcome: Past, present, future. In: Lester BM, (Eds.) / Clinics in perinatology: Prenatal drug exposure and child outcome. Philadelphia, PA: WB Saunders, 1999:1鈥?6.
  18. Lukas SE. / Proceedings of the National Consensus Meeting on the use, abuse, and sequelae of methamphetamine with implications for prevention, treatment, and research. Washington, DC: Center for Substance Abuse Treatment, 1997.
  19. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey on Drug Use and Health, 2002 and 2003.
  20. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Summary of findings from the 1999 National Household Survey on Drug Abuse (DHHS Publiciation No SMA00-3466, NHSDA Series H12, Rockville, MD.
  21. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, National Survey on Drug Use and Health, 2002 and 2003.
  22. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, DASIS Report: Primary Methamphetamine/Amphetamine Treatment Admissions 1992鈥?002, September 17, 2004.
  23. Miller MA. History and epidemiology of amphetamine abuse in the United States. In: Klee H, (Ed.) / Amphetamine misuse: International perspectives on current trends. Amsterdam: Harwood Academic, 1997:113.
  24. Zhang Z. Drug and Alcohol Use and Related Matters among Arrestees. ADAM Program 2003, National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.
  25. Acuff-Smith KD, George M, Lorens SA, Vorhees CV. Preliminary evidence for methamphetamine-induced behavioral and ocular effects in rat offspring following exposure during early organogenesis. / Psychopharmacology 1992;109(3):255鈥?3. CrossRef
  26. Yamamoto Y, Yamanoto K, Fukui Y, Kurishita A. Teratogenic effects of methamphetamine in mice. / Jpn J Legal Med 1992;46(2):126鈥?31.
  27. Cho DH, Lyu HM, Lee HB, Kim PY, Chin K. Behavioral teratogenicity of methamphetamine. / J Toxicol Sci Suppl 1991;1:37鈥?9.
  28. Cabrera TM, Levy AD, Li Q, van de Kar LD, Battaglia G. Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: Evidence for selective long-term dysfunction of serotonin pathways in brain. / Synapse 1993;15(3):198鈥?8. CrossRef
  29. Weissman AD, Caldecott-Hazard S. Developmental neurotoxicity to methamphetamines. / Clin Exp Pharmacol Physiol 1995;22(5):372鈥?. CrossRef
  30. Eriksson M, Larsson G, Winbladh B, Zetterstrom R. The influence of amphetamine addiction on pregnancy and the newborn infant. / Acta Paediatr Scand 1978;67:95鈥?. CrossRef
  31. Eriksson M, Larsson G, Zetterstrom R. Amphetamine addiction and pregnancy. II. Pregnancy, delivery, and the neonatal period. Socio-medical aspects. / Acta Obstet Gynecol Scand 1981;60:253鈥?. CrossRef
  32. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates. / J Pediatr 1989;115:770鈥?. CrossRef
  33. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. / J Pediatr 1987;111:571鈥?. CrossRef
  34. Little BB, Snell LM, Gilstrap LC. Methamphetamine abuse during pregnancy: Outcome and fetal effects. / Obstet Gynecol 1988;72:541鈥?.
  35. Struthers JM, Hansen RL. Visual recognition memory in drug-exposed infants. / J Dev Behav Pediatr 1992;13:108鈥?1. CrossRef
  36. Billing L, Eriksson M, Larsson G, Zetterstrom R. Amphetamine addiction and pregnancy. III. One year follow-up of the children. Psychosocial and pediatric aspects. / Acta Paediatr Scand 1980;69:675鈥?0. CrossRef
  37. Billing L, Eriksson M, Steneroth G, Zetterstrom R. Pre-school children of amphetamine-addicted mothers. I. Somatic and psychomotor development. / Acta Paediatr Scand 1985;74:179鈥?4. CrossRef
  38. Billing L, Eriksson M, Steneroth G, Zetterstrom R. Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. / Child Abus Negl 1988;12:503鈥?. CrossRef
  39. Billing L, Eriksson M, Jonsson B, Steneroth G. The influence of environmental factors on behavioral problems in 8-year-old children exposed to amphetamine during fetal life. / Child Abus Negl 1994;18:3鈥?. CrossRef
  40. Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. / Acta Paediatr 1996;85:204鈥?. CrossRef
  41. Catanzarite VA, Stein DA. 鈥楥rystal鈥?and pregnancy鈥擬ethamphetamine-associated maternal deaths. / West J Med 1995;162:454鈥?.
  42. Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. / Obstet Gynecol Clin North Am 1998;25(1):119鈥?8. CrossRef
  43. U.S. Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse. National Pregnancy and Health Survey: Drug Use among Women Delivering Live Births: 1992. NIH Publication No. 96鈥?819, 1996.
  44. Derauf C, Katz AR, Frank DA, Grandinetti A, Easa D. The prevalence of methamphetamine and other drug use during pregnancy in Hawaii. / J Drug Issues 2003;2鈥?6.
  45. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Smoking during pregnancy鈥擴nited States, 1990鈥?002. / MMWR 2004;53:911鈥?7.
  46. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Surveillance Summaries, Surveillance for disparities in maternal health-related behaviors鈥攕elected states, Pregnancy Risk Assessment Monitoring System (PRAMS), 2000-2001. MMWR 2004 53 SS4 1鈥?4.
  47. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. / Obstet Gynecol 2003;101(2):374鈥?. CrossRef
  48. Leonardson GR, Loudenberg R. Risk factors for alcohol use during pregnancy in a multistate study. / Neroutoxicol Teratol 2003;25(6):651鈥?. CrossRef
  49. Fuani EF, White J, Lee MJ, Allen M, Kuczynski E. Compliance with prenatal care visits in substance abusers. / J Mat Fetal Neonatal Med 2003;14(5):329鈥?2. CrossRef
  50. Bauer CR, Shankaran S, Bada HS, Lester B, Wright LL, Krause-Steinrauf H, Smeriglio VL, Finnegan LP, Maza PL, Verter J. The Maternal Lifestyle Study: Drug exposure during pregnancy and short-term maternal outcomes. / Am J Obstet Gynecol 2002;186(3):487鈥?5. CrossRef
  51. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Lu J, Finnegan LP, Maza PL. The maternal lifestyle study: Effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. / Pediatrics 2002;110(6):1182鈥?2. CrossRef
  52. Hollingshead AB. / Four factor index of social status. Department of Sociology: Yale University, New Haven, CT, 1975.
  53. El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylanck L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. / J Perinatol 2003;23(5):354鈥?0. CrossRef
  54. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Rieber C, Vandersloot D, Zweben J, and the Methamphetamine Treatment Project Corporate Authors. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. / Addiction 2004;99:708鈥?7. CrossRef
  55. Finkelstein N. Treatment programming for alcohol and drug-dependent pregnant women. Special Issue: Maternal Drug Use: Issues and Implications for Mother and Child. / Inter J Addict 1993;28(13):1275鈥?09.
  56. Svikis DS, Haug N, Lee J, Timpson R. Predictors of treatment participation and retention in an intensive outpatient program for pregnant drug abusing women. In: Harris LS, (Ed.), / National Institute of Drug Abuse Research Monograph Series 163. Rockville, MD: National Institute on Drug Abuse, 1996:351.
  
• 作者单位：Amelia M. Arria PhD (1) (11)
  Chris Derauf MD (2)
  Linda L. LaGasse PhD (3)
  Penny Grant MD (4)
  Rizwan Shah MD (5)
  Lynne Smith MD (6)
  William Haning MD (7)
  Marilyn Huestis PhD (8)
  Arthur Strauss MD (9)
  Sheri Della Grotta MPH (3)
  Jing Liu PhD (3)
  Barry Lester PhD (10)
  
  1. Center for Substance Abuse Research, University of Maryland, College Park, Maryland, USA
  11. Center for Substance Abuse Research, University of Maryland, College Park, Maryland, USA
  2. Department of Pediatrics, University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii, USA
  3. Infant Development Center, Women and Infants鈥?Hospital, Providence, Rhode Island, USA
  4. University of Oklahoma College of Medicine, Tulsa, Oklahoma, USA
  5. Blank Children's Hospital, Des Moines, Iowa, USA
  6. Harbor-UCLA Medical Center, Torrance, California, USA
  7. University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii, USA
  8. Clinical Pharmacology and Therapeutics Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA
  9. Long Beach Memorial Medical Center, Long Beach, California, USA
  10. Infant Development Center, Women and Infants鈥?Hospital, and Brown Medical School, Providence, Rhode Island, USA
  

文摘